File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3233/JND-180376
- Scopus: eid_2-s2.0-85066892378
- PMID: 31127727
- WOS: WOS:000685099200007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service
Title | Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service |
---|---|
Authors | Westra, DSchouten, MIStunnenberg, BCKusters, BSaris, CGJErasmus, CEvan Engelen, BGBulk, SVerschuuren-Bemelmans, CCGerkes, EHde Geus, Cvan der Zwaag, PAChan, SChung, BBarge-Schaapveld, DQCMKriek, MSznajer, Yvan Spaendonck-Zwarts, Kvan der Kooi, AJKrause, ASchonewolf-Greulich, Bde Die-Smu8lders, CSallevelt, SCEHKrapels, IPCRasmussen, MMaystadt, IKievit, AJAWitting, NPennings, MMeijer, RGillissen, CKamsteeg, EJVoermans, NC |
Keywords | Neuromuscular diseases exome sequencing genetics neurology myopathies |
Issue Date | 2019 |
Publisher | IOS Press. The Journal's web site is located at https://www.iospress.nl/journal/journal-of-neuromuscular-diseases/ |
Citation | Journal of Neuromuscular Diseases, 2019, v. 6 n. 2, p. 241-258 How to Cite? |
Abstract | Background:Neuromuscular disorders (NMDs) are clinically and genetically heterogeneous. Accurate molecular genetic diagnosis can improve clinical management, provides appropriate genetic counseling and testing of relatives, and allows potential therapeutic trials. Objective:To establish the clinical utility of panel-based whole exome sequencing (WES) in NMDs in a population with children and adults with various neuromuscular symptoms. Methods:Clinical exome sequencing, followed by diagnostic interpretation of variants in genes associated with NMDs, was performed in a cohort of 396 patients suspected of having a genetic cause with a variable age of onset, neuromuscular phenotype, and inheritance pattern. Many had previously undergone targeted gene testing without results. Results:Disease-causing variants were identified in 75/396 patients (19%), with variants in the three COL6-genes (COL6A1, COL6A2 and COL6A3) as the most common cause of the identified muscle disorder, followed by variants in the RYR1 gene. Together, these four genes account for almost 25% of cases in whom a definite genetic cause was identified. Furthermore, likely pathogenic variants and/or variants of uncertain significance were identified in 95 of the patients (24%), in whom functional and/or segregation analysis should be used to confirm or reject the pathogenicity. In 18% of the cases with a disease-causing variant of which we received additional clinical information, we identified a genetic cause in genes of which the associated phenotypes did not match that of the patients. Hence, the advantage of panel-based WES is its unbiased approach. Conclusion:Whole exome sequencing, followed by filtering for NMD genes, offers an unbiased approach for the genetic diagnostics of NMD patients. This approach could be used as a first-tier test in neuromuscular disorders with a high suspicion of a genetic cause. With uncertain results, functional testing and segregation analysis are needed to complete the evidence. |
Persistent Identifier | http://hdl.handle.net/10722/272291 |
ISSN | 2023 Impact Factor: 3.2 2023 SCImago Journal Rankings: 0.949 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Westra, D | - |
dc.contributor.author | Schouten, MI | - |
dc.contributor.author | Stunnenberg, BC | - |
dc.contributor.author | Kusters, B | - |
dc.contributor.author | Saris, CGJ | - |
dc.contributor.author | Erasmus, CE | - |
dc.contributor.author | van Engelen, BG | - |
dc.contributor.author | Bulk, S | - |
dc.contributor.author | Verschuuren-Bemelmans, CC | - |
dc.contributor.author | Gerkes, EH | - |
dc.contributor.author | de Geus, C | - |
dc.contributor.author | van der Zwaag, PA | - |
dc.contributor.author | Chan, S | - |
dc.contributor.author | Chung, B | - |
dc.contributor.author | Barge-Schaapveld, DQCM | - |
dc.contributor.author | Kriek, M | - |
dc.contributor.author | Sznajer, Y | - |
dc.contributor.author | van Spaendonck-Zwarts, K | - |
dc.contributor.author | van der Kooi, AJ | - |
dc.contributor.author | Krause, A | - |
dc.contributor.author | Schonewolf-Greulich, B | - |
dc.contributor.author | de Die-Smu8lders, C | - |
dc.contributor.author | Sallevelt, SCEH | - |
dc.contributor.author | Krapels, IPC | - |
dc.contributor.author | Rasmussen, M | - |
dc.contributor.author | Maystadt, I | - |
dc.contributor.author | Kievit, AJA | - |
dc.contributor.author | Witting, N | - |
dc.contributor.author | Pennings, M | - |
dc.contributor.author | Meijer, R | - |
dc.contributor.author | Gillissen, C | - |
dc.contributor.author | Kamsteeg, EJ | - |
dc.contributor.author | Voermans, NC | - |
dc.date.accessioned | 2019-07-20T10:39:24Z | - |
dc.date.available | 2019-07-20T10:39:24Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Journal of Neuromuscular Diseases, 2019, v. 6 n. 2, p. 241-258 | - |
dc.identifier.issn | 2214-3599 | - |
dc.identifier.uri | http://hdl.handle.net/10722/272291 | - |
dc.description.abstract | Background:Neuromuscular disorders (NMDs) are clinically and genetically heterogeneous. Accurate molecular genetic diagnosis can improve clinical management, provides appropriate genetic counseling and testing of relatives, and allows potential therapeutic trials. Objective:To establish the clinical utility of panel-based whole exome sequencing (WES) in NMDs in a population with children and adults with various neuromuscular symptoms. Methods:Clinical exome sequencing, followed by diagnostic interpretation of variants in genes associated with NMDs, was performed in a cohort of 396 patients suspected of having a genetic cause with a variable age of onset, neuromuscular phenotype, and inheritance pattern. Many had previously undergone targeted gene testing without results. Results:Disease-causing variants were identified in 75/396 patients (19%), with variants in the three COL6-genes (COL6A1, COL6A2 and COL6A3) as the most common cause of the identified muscle disorder, followed by variants in the RYR1 gene. Together, these four genes account for almost 25% of cases in whom a definite genetic cause was identified. Furthermore, likely pathogenic variants and/or variants of uncertain significance were identified in 95 of the patients (24%), in whom functional and/or segregation analysis should be used to confirm or reject the pathogenicity. In 18% of the cases with a disease-causing variant of which we received additional clinical information, we identified a genetic cause in genes of which the associated phenotypes did not match that of the patients. Hence, the advantage of panel-based WES is its unbiased approach. Conclusion:Whole exome sequencing, followed by filtering for NMD genes, offers an unbiased approach for the genetic diagnostics of NMD patients. This approach could be used as a first-tier test in neuromuscular disorders with a high suspicion of a genetic cause. With uncertain results, functional testing and segregation analysis are needed to complete the evidence. | - |
dc.language | eng | - |
dc.publisher | IOS Press. The Journal's web site is located at https://www.iospress.nl/journal/journal-of-neuromuscular-diseases/ | - |
dc.relation.ispartof | Journal of Neuromuscular Diseases | - |
dc.subject | Neuromuscular diseases | - |
dc.subject | exome sequencing | - |
dc.subject | genetics | - |
dc.subject | neurology | - |
dc.subject | myopathies | - |
dc.title | Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service | - |
dc.type | Article | - |
dc.identifier.email | Chan, S: sophehs@hku.hk | - |
dc.identifier.email | Chung, B: bhychung@hku.hk | - |
dc.identifier.authority | Chan, S=rp02210 | - |
dc.identifier.authority | Chung, B=rp00473 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.3233/JND-180376 | - |
dc.identifier.pmid | 31127727 | - |
dc.identifier.scopus | eid_2-s2.0-85066892378 | - |
dc.identifier.hkuros | 298765 | - |
dc.identifier.volume | 6 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 241 | - |
dc.identifier.epage | 258 | - |
dc.identifier.isi | WOS:000685099200007 | - |
dc.publisher.place | Netherlands | - |
dc.identifier.issnl | 2214-3599 | - |